Alison Ritter
#171,726
Most Influential Person Now
Australian educator and drug and alcohol researcher
Alison Ritter's AcademicInfluence.com Rankings
Download Badge
Education Psychology
Why Is Alison Ritter Influential?
(Suggest an Edit or Addition)According to Wikipedia, Alison Joan Ritter is an Australian academic whose research focuses on illicit drug use and policy. As of 2021 she is a full professor and director of the Drug Policy Modelling Program at the University of New South Wales.
Alison Ritter's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Speaking truth to power. (2008) (340)
- The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS). (2005) (235)
- A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs. (2006) (215)
- One year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS). (2006) (132)
- How do drug policy makers access research evidence? (2009) (126)
- Serious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD). (2004) (121)
- Producing the 'problem of drugs': A cross national-comparison of 'recovery' discourse in two Australian and British reports. (2015) (110)
- Examining the construction and representation of drugs as a policy problem in Australia's National Drug Strategy documents 1985-2010. (2014) (93)
- Factors associated with 12 months continuous heroin abstinence: findings from the Australian Treatment Outcome Study (ATOS). (2005) (90)
- Studying illicit drug markets: Disciplinary contributions (2006) (87)
- LAAM maintenance vs methadone maintenance for heroin dependence. (2002) (82)
- A randomised trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care setting (2005) (75)
- The ethics of reimbursing injecting drug users for public health research interviews: what price are we prepared to pay? (2003) (74)
- Paying research participants: a study of current practices in Australia (2005) (70)
- Naltrexone in the Treatment of Heroin Dependence: Relationship with Depression and Risk of Overdose (2002) (68)
- The Ethics of Paying Drug Users Who Participate in Research: A Review and Practical Recommendations (2006) (67)
- High-frequency drug purity and price series as tools for explaining drug trends and harms in Victoria, Australia. (2015) (64)
- Implementing buprenorphine treatment in community settings in Australia: experiences from the Buprenorphine Implementation Trial. (2004) (59)
- The deterrent effects of Australian street-level drug law enforcement on illicit drug offending at outdoor music festivals. (2017) (59)
- Take-Home Naloxone for the Emergency Interim Management of Opioid Overdose: The Public Health Application of an Emergency Medicine (2019) (57)
- Pill testing or drug checking in Australia: Acceptability of service design features (2018) (55)
- Networks within networks: using multiple link types to examine network structure and identify key actors in a drug trafficking operation (2015) (53)
- The relationship between take-away methadone policies and methadone diversion. (2005) (53)
- Optimal targeting of Hepatitis C virus treatment among injecting drug users to those not enrolled in methadone maintenance programs. (2010) (52)
- Cessation of methadone maintenance treatment using buprenorphine: transfer from methadone to buprenorphine and subsequent buprenorphine reductions. (2003) (52)
- The productive techniques and constitutive effects of 'evidence-based policy' and 'consumer participation' discourses in health policy processes. (2017) (50)
- The Use of Actor-Level Attributes and Centrality Measures to Identify Key Actors (2015) (49)
- Naltrexone in the treatment of heroin dependence: a literature review (2000) (48)
- Methadone injecting in Australia: a tale of two cities. (1999) (47)
- Policing Australia’s ‘heroin drought’: using an agent-based model to simulate alternative outcomes (2008) (46)
- Models of policy-making and their relevance for drug research. (2010) (46)
- The influence of the therapeutic relationship in treatment for alcohol dependency. (2002) (43)
- Problems, policy and politics: making sense of Australia's ‘ice epidemic’ (2014) (42)
- Public opinion and drug policy in Australia: engaging the 'affected community'. (2013) (42)
- Stigma and subjectivities: Examining the textured relationship between lived experience and opinions about drug policy among people who inject drugs (2015) (42)
- A SUMMARY OF DIVERSION PROGRAMS FOR DRUG AND DRUG-RELATED OFFENDERS IN AUSTRALIA (2008) (40)
- Measuring research influence on drug policy: a case example of two epidemiological monitoring systems. (2013) (38)
- Making medicine; producing pleasure: A critical examination of medicinal cannabis policy and law in Victoria, Australia. (2017) (36)
- Comparative policy analysis for alcohol and drugs: Current state of the field. (2016) (36)
- ‘Naloxone works’: The politics of knowledge in ‘evidence-based’ drug policy (2017) (35)
- Australian clinician attitudes towards contingency management: comparing down under with America. (2007) (34)
- Cost Benefit Analysis of Two Policy Options for Cannabis: Status Quo and Legalisation (2014) (34)
- Criminal network vulnerabilities and adaptations (2017) (33)
- Naltrexone maintenance for heroin dependence: uptake, attrition and retention. (2004) (32)
- Methods for comparing drug policies--the utility of composite drug harm indexes. (2009) (32)
- Randomized controlled trial of a brief behavioural intervention for reducing hepatitis C virus risk practices among injecting drug users. (2004) (32)
- Measuring Unmet Demand for Alcohol and Other Drug Treatment: The Application of an Australian Population-Based Planning Model (2019) (31)
- How can and do empirical studies influence drug policies? Narratives and complexity in the use of evidence in policy making (2013) (29)
- Illicit drugs policy through the lens of regulation. (2010) (29)
- Medications used in overdose and how they are acquired – an investigation of cases attending an inner Melbourne emergency department (2010) (29)
- Improving drug policy: The potential of broader democratic participation. (2018) (28)
- More than problem-solving: critical reflections on the 'problematisation' of alcohol-related violence in Kings Cross. (2012) (28)
- Key Considerations in Planning for Substance Use Treatment: Estimating Treatment Need and Demand (2019) (28)
- Contingency management: perspectives of Australian service providers. (2007) (28)
- A systematic review of modelling approaches in economic evaluations of health interventions for drug and alcohol problems (2016) (27)
- Retail price as an outcome measure for the effectiveness of drug law enforcement. (2010) (27)
- Cost-effectiveness of center-based compulsory rehabilitation compared to community-based voluntary methadone maintenance treatment in Hai Phong City, Vietnam. (2016) (26)
- National clinical guidelines and procedures for the use of buprenorphine in the treatment of heroin dependence (2009) (26)
- Assessing the concordance between illicit drug laws on the books and drug law enforcement: Comparison of three states on the continuum from "decriminalised" to "punitive". (2017) (26)
- Short-term Outcomes for the Treatment of Heroin Dependence: Findings From the Australian Treatment Outcome Study (ATOS) (2006) (26)
- Withdrawal from methadone maintenance treatment: prognosis and participant perspectives (2001) (26)
- AN ASSESSMENT OF ILLICIT DRUG POLICY IN AUSTRALIA (1985 TO 2010): THEMES AND TRENDS (2011) (25)
- The costs and consequences of three policy options for reducing heroin dependency. (2007) (25)
- Drug law enforcement in an agent-based model : Simulating the disruption to street-level drug markets (2008) (25)
- Recasting Participation in Drug Policy (2018) (24)
- Quantifying the societal cost of methamphetamine use to Australia. (2018) (23)
- A randomized trial comparing levo-alpha acetylmethadol with methadone maintenance for patients in primary care settings in Australia. (2003) (23)
- Effective drug policy: a new approach demonstrated in the Drug Policy Modelling Program. (2007) (23)
- Examining the opinions of people who use drugs towards drug policy in Australia (2014) (23)
- The political and scientific challenges in evaluating compulsory drug treatment centers in Southeast Asia (2017) (22)
- Comparing Alcohol Policies Between Countries: Science or Silliness? (2007) (22)
- Drug use in Australia : preventing harm (2004) (22)
- "A more accurate understanding of drug use": A critical analysis of wastewater analysis technology for drug policy. (2019) (21)
- Alcohol and other drug (AOD) staffing and their workplace: examining the relationship between clinician and organisational workforce characteristics and treatment outcomes in the AOD field (2020) (21)
- Reducing stigma and discrimination for people experiencing problematic alcohol and other drug use. (2018) (21)
- Illicit drug policy: Scoping the interventions and taxonomies (2008) (20)
- Dynamic compartmental model of trends in Australian drug use (2007) (20)
- Drug consumption rooms: A systematic review of evaluation methodologies (2019) (20)
- The business cycle and drug use in Australia: evidence from repeated cross-sections of individual level data. (2011) (20)
- Where is the pleasure? (2014) (20)
- New Australian guidelines for the treatment of alcohol problems: an overview of recommendations (2021) (19)
- ‘Drug dogs unleashed’: An historical and political account of drug detection dogs for street-level policing of illicit drugs in New South Wales, Australia (2017) (19)
- The Drug Problem in the Americas Organization of American States Organization of American States, 2013ISBN 978 0 8270 6006 7; Part 1: 108; part 2: 79 (2013) (18)
- The privileged role of researchers in “evidence-based” policy: implications and engagement of other voices (2015) (18)
- Maintenance Pharmacotherapy for Opioid Dependence and SF-36 Health Status: A Comparison With General Population Norms and Other Chronic Disorders (2006) (18)
- Alcohol and other drug treatment policy in Australia (2016) (18)
- Subsidising patient dispensing fees: the cost of injecting equity into the opioid pharmacotherapy maintenance system. (2012) (18)
- Characteristics of medication overdose presentations to the ED: how do they differ from illicit drug overdose and self-harm cases? (2010) (17)
- Making change happen: a case study of the successful establishment of a peer-administered naloxone program in one Australian jurisdiction. (2014) (17)
- Understanding policy persistence-The case of police drug detection dog policy in NSW, Australia. (2017) (17)
- The relationship between economic conditions and substance use and harm. (2011) (17)
- Effects of Pharmacotherapies for Opioid Dependence on Participants' Criminal Behaviour and Expenditure on Illicit Drugs: An Australian National Evaluation (NEPOD) (2006) (17)
- Screening and intervention for mental health problems in alcohol and other drug settings: Can training change practitioner behaviour? (2011) (16)
- Using the Advocacy Coalition Framework and Multiple Streams policy theories to examine the role of evidence, research and other types of knowledge in drug policy (2018) (15)
- A randomized control trial of group counseling in a naltrexone treatment program. (2004) (15)
- Monograph no. 06: A systematic review of harm reduction. (2005) (14)
- Decriminalisation of drug use and possession in Australia – A briefing note. (2016) (13)
- Outcomes of compulsory detention compared to community-based voluntary methadone maintenance treatment in Vietnam. (2018) (13)
- Australian threshold quantities for 'drug trafficking': Are they placing drug users at risk of unjustified sanction? (2014) (13)
- "It's about bloody time": Perceptions of people who use drugs regarding drug law reform. (2019) (12)
- Exploring the existence of drug policy ‘ideologies’ in Australia (2013) (12)
- Routine opioid outcome monitoring in community pharmacy: Pilot implementation study protocol. (2019) (12)
- Following the money: Mapping the sources and funding flows of alcohol and other drug treatment in Australia. (2016) (12)
- The nature of uncertainty (2008) (12)
- The Role of Research Evidence in Drug Policy Development in Australia (2011) (12)
- Making drug policy in summer-drug checking in Australia as providing more heat than light. (2019) (12)
- A New Framework for Evaluating the Potential for Drug Law to Produce Stigma: Insights from an Australian Study (2017) (11)
- Perceptions of purchasing and payment mechanisms in alcohol and other drug treatment services in Australia: A qualitative study involving alcohol and other drug service providers and purchasers of treatment. (2020) (11)
- Making legitimacy: Drug user representation in United Nations drug policy settings. (2020) (11)
- The legal regulation of drugs and role of government: Perspectives from people who use drugs. (2019) (11)
- Separating politics and scientific research on heroin prescription (2002) (11)
- Health expenditure on alcohol and other drug treatment in Australia (2012/2013). (2015) (10)
- Training Primary Health Care Professionals to Provide Buprenorphine and LAAM Treatment (2002) (10)
- Mapping regulatory models for medicinal cannabis: a matrix of options. (2017) (10)
- Monograph No. 27: Criminal justice responses relating to personal use and possession of illicit drugs: The reach of Australian drug diversion programs and barriers and facilitators to expansion (2019) (10)
- Preferences for policy options for cannabis in an Australian general population: A discrete choice experiment. (2014) (10)
- Illicit Drugs, Policing and the Evidence-Based Policy Paradigm. (2013) (10)
- Drug policy coordination: identifying and assessing dimensions of coordination. (2013) (10)
- How profitable is methamphetamine dealing in Australia? (2012) (10)
- How Patterns of Injecting Drug Use Evolve in a Cohort of People Who Inject Drugs (2015) (9)
- Methamphetamine alarm: are we forgetting what we know? (2007) (9)
- Routine opioid outcome monitoring in community pharmacy: Outcomes from an open-label single-arm implementation-effectiveness pilot study. (2020) (9)
- Expanding the deliberations about the research-policy gap: useful lessons from the literature (2010) (9)
- Patients Who Attend the Emergency Department Following Medication Overdose: Self-reported Mental Health History and Intended Outcomes of Overdose (2012) (9)
- Conceptualising 'balance' in national drug policy. (2010) (9)
- Recovery from alcohol problems in the absence of treatment: A qualitative narrative analysis. (2020) (9)
- A ‘promising tool’? A critical review of the social and ethico-political effects of wastewater analysis in the context of illicit drug epidemiology and drug policy (2019) (9)
- Alcohol and other drug treatment commissioning and purchasing: Is it health care or social‐welfare? (2018) (9)
- Systematic review of untreated remission from alcohol problems: Estimation lies in the eye of the beholder. (2019) (9)
- A critical examination of the introduction of drug detection dogs for policing of illicit drugs in New South Wales, Australia using Kingdon’s ‘multiple streams’ heuristic (2017) (8)
- New Australian lesbian, gay, bisexual and transgender research--and the need for more. (2015) (8)
- The 15th International Conference on the Reduction of Drug Related Harm, Melbourne, Australia, 20–24th April 2004 (2004) (8)
- Training primary health care professionals to prvide Buprenorphine and LAAM treatment (2002) (8)
- Confronting the challenges of conducting a CBA of cannabis policies (2013) (8)
- DRUG POLICY MODELLING PROJECT MONOGRAPH 06 A SYSTEMATIC REVIEW OF HARM REDUCTION (2005) (8)
- Estimating met demand for alcohol and other drug treatment in Australia. (2016) (7)
- Is quantity more important than quality? (2011) (7)
- Intangible outcomes from a policy change: using contingent valuation to quantify potential stigma from a cannabis offence (2014) (7)
- Legislating thresholds for drug trafficking: a policy development case study from New South Wales, Australia. (2014) (7)
- Medicinal cannabis in Australia – Framing the regulatory options (2015) (7)
- Why the alcohol and other drug community should support gay marriage. (2012) (7)
- SimARC: An Ontology-driven Behavioural Model of Alcohol Abuse (2011) (7)
- The impact of community pharmacy dispensing fees on the introduction of buprenorphine - naloxone in Australia. (2007) (7)
- Monograph no. 15: Priority areas in illicit drug policy: Perspectives of policy makers. (2007) (6)
- Indexes as a Metric for Drug and Alcohol Policy Evaluation and Assessment (2017) (6)
- Harm reduction programs and policy in Australia: barriers and enablers to effective implementation (2020) (6)
- The details of decriminalization: Designing a non-criminal response to the possession of drugs for personal use. (2022) (6)
- Improving knowledge on law enforcement in drug policy. (2017) (6)
- Revision of the Australian guidelines to reduce health risks from drinking alcohol (2021) (6)
- Twenty years of (non)reform in Victorian alcohol and other drug treatment policy. (2016) (6)
- Explaining the declining rates of past year cannabis use in Australia: A first pass (2017) (6)
- Redressing responses to the treatment gap for people with alcohol problems: The overlooked role of untreated remission from alcohol problems (2020) (6)
- SimDrug: A multi-agent system tackling the complexity of illicit drug markets in Australia (2006) (6)
- Patterns of drug preference and use among people who inject drugs in Melbourne, Australia (2015) (6)
- Deemed Supply in Australian Drug Trafficking Laws: A Justifiable Legal Provision? (2015) (6)
- Building a microsimulation model of heroin use careers in Australia (2015) (5)
- 'Trafficking' or 'personal use': do people who regularly inject drugs understand Australian drug trafficking laws? (2014) (5)
- Heroin Markets in Australia: Current Understandings and Future Possibilities (Monograph No. 09) (2005) (5)
- Reported value of cannabis seizures in Australian newspapers: are they accurate? (2011) (5)
- The relationship between drug price and purity and population level harm (2020) (5)
- Fast‐tracking implementation through trial design: the case of buprenorphine treatment in Victoria (2009) (5)
- A conceptual schema for government purchasing arrangements for Australian alcohol and other drug treatment. (2016) (5)
- Applying a 'Harm to Others' research framework to illicit drugs: Political discourses and ambiguous policy implications. (2020) (5)
- DRUG POLICY MODELLING PROGRAM MONOGRAPH 18 THE COORDINATION OF AUSTRALIAN ILLICIT DRUG POLICY: A GOVERNANCE PERSPECTIVE (2010) (4)
- Valuing families' preferences for drug treatment: a discrete choice experiment. (2020) (4)
- The Processes of Reform in Victoria's Alcohol and Other Drug Sector, 2011-2014 (2014) (4)
- Estimating the prevalence of individuals likely to use publicly funded alcohol treatment services: an indirect estimation technique. (2008) (4)
- Demand study for alcohol treatment services in the Northern Territory (2019) (4)
- Collaborative Governance in the Reform of Western Australia's Alcohol and Other Drug Sector (2016) (4)
- Buprenorphine for the treatment of heroin dependence (2001) (4)
- The impact of compliance with a compulsory model of drug diversion on treatment engagement and reoffending (2018) (4)
- Tackling ‘drug-related’ crime: Are there merits in diverting drug-misusing defendants to treatment? Findings from an Australian case study (2016) (4)
- Commentary on Vrolijk et al. (2017): The paradox of the quality control problem. (2017) (4)
- Monograph no. 02: Drug policy interventions: A omprehensive list and a review of classification schemes. (2005) (3)
- 'Miracle cure' or 'liquid handcuffs': reporting on naltrexone and methadone in the Australian print media. (2014) (3)
- SimDrug: tackling the complexity of illicit drug markets in Australia (2006) (3)
- LEGAL THRESHOLDS FOR SERIOUS DRUG OFFENCES: EXPERT ADVICE TO THE ACT ON DETERMINING AMOUNTS FOR TRAFFICABLE, COMMERCIAL AND LARGE COMMERCIAL DRUG OFFENCES (2011) (3)
- Moral framings in the Australian parliamentary debate on drug testing of welfare recipients (2021) (3)
- Not to Lose Sight of the Bigger Picture: The Case of Therapeutic Communities (TC) Research in Closed Settings in Thailand (2013) (3)
- An agent-based model of alcohol use and abuse: SimARC (2011) (2)
- A lifetime individual sampling model (ISM) for heroin use and treatment evaluation in Australia (2014) (2)
- The cost effectiveness of buprenorphine [an alternative to methadone] in a primary care setting (2003) (2)
- Strengthening advocacy efforts with empirical evidence: A case example of the conduct, uptake and utilisation of research in drug policy decision-making in Vietnam. (2017) (2)
- Structural and functional changes in an Australian high-level drug trafficking network after exposure to supply changes. (2020) (2)
- Contracting treatment services in Australia: Do measures adhere to best practice? (2020) (2)
- Quality of life as a predictor of time to heroin relapse among male residents following release from compulsory rehabilitation centres in Vietnam. (2020) (2)
- Mental Health Ontologies: How We Talk About Mental Health, and Why it Matters in the Digital AgeJannaHastings, Exeter, UK: University of Exeter Press, 2020. ISBN 9781905816576 (2021) (2)
- Modelling heroin careers over 40 years: Social costs (2017) (2)
- Pill testing policy: A comparative analysis using the Advocacy Coalition Framework. (2021) (2)
- SimDrug: Exploring the Complexity of Illicit Drug Markets. (2006) (2)
- Is health or social welfare the right question? Response to commentaries. (2019) (2)
- DRUG POLICY MODELLING PROJECT MONOGRAPH 08 A REVIEW OF APPROACHES TO STUDYING ILLICIT DRUG MARKETS (2005) (2)
- Ensuring the policy relevance of population health research: experiences from the Drug Policy Modelling Program. (2011) (2)
- Improving the management of ignorance and uncertainty: A case illustrating integration in collaboration (2008) (2)
- Alison Ritter on Friedman et al.'s “Has United States Drug Policy Failed? And How Could We Know?” Policy as Structured Interaction, Engaging Multiple Voices (2012) (2)
- Harm reduction and the opioid crisis: Emerging policy challenges. (2019) (2)
- REMEDIATION AND PROPERTY VALUES: THE COSTS OF CLANDESTINE METHAMPHETAMINE MANUFACTURING IN AUSTRALIA (2018) (1)
- Words matter: A commentary on the new UK drug strategy. (2022) (1)
- A new approach to developing clinically-based guidelines: the experience of developing guidelines for management of drug dependent women and neonates and for cannabis dependence (2012) (1)
- Distinguishing personal use of drugs from drug supply: Approaches and challenges. (2022) (1)
- Are market mechanisms associated with alcohol and other drug treatment outcomes? (2021) (1)
- Mandatory alcohol and drug treatment: what is it and does it work? (2019) (1)
- Australian Trends in Drug User and Drug Dealer Arrest Rates: 1993 to 2006–07 (2011) (1)
- Advancing the science, methods and practices of drug policy research. (2016) (1)
- Do cryptomarkets users differ in reporting emergency medical treatment following MDMA, LSD and cocaine use? (2020) (1)
- The Australian Alcohol Treatment Outcome Measure (AATOM-R) Psychometric properties (2008) (1)
- Corrigendum to "Examining the construction and representation of drugs as a policy problem in Australia's National Drug Strategy documents 1985-2010" [Int. J. Drug Policy 25 (2014) 81-87]. (2016) (1)
- International Drug Control into the 21st Century (2009) (1)
- Drug Policy Modelling Program submission to the ACT Legislative Assembly Inquiry into the Drugs of Dependence ( Personal Use ) Amendment Bill 2021 (2021) (1)
- Naltrexone maintenance treatment (2009) (1)
- Living with Drugs (2007) (1)
- MODELLING PROJECT MONOGRAPH 02 DRUG POLICY INTERVENTIONS : A COMPREHENSIVE LIST AND A REVIEW OF CLASSIFICATION SCHEMES (2006) (1)
- Examining untreated and treated alcohol problem resolution in an Australian online survey sample. (2021) (1)
- Editorial for special issue: Vulnerable groups: Addiction research, policy and practice. (2020) (1)
- The association between involuntary alcohol treatment and subsequent emergency department visits and hospitalisations: a Bayesian analysis of treated patients and matched controls. (2021) (1)
- Book Review (2007) (0)
- Multiplexity in a drug trafficking network: Using multiple types of directed ties to illuminate network structure (2013) (0)
- Navigating the grey: Experiences of incremental cannabis reform in Australia (2022) (0)
- Individuals with opioid dependence who leave drug treatment have higher overdose and death rates than those still in treatment (2004) (0)
- TheNationalDrugandAlcoholResearchCentre(NDARC)isapremierresearchinstitutioninSydney,Australiaandis r ecognisedinternationallyasaResearchCentreofExcellence. NDARCwasestablishedattheUniversityofNewSouthWales ( UNSW) inMay 1986 andofficiallyopenedinNovember 1987. ItisfundedbytheAustraliangovernmentaspa (2013) (0)
- Editing the International Journal of Drug Policy. (2020) (0)
- Celebrating Robin Room. (2014) (0)
- Reducing drug‐related harm: Australia leads the way (2005) (0)
- Co-morbid mental and substance use disorders – a meta-review of treatment effectiveness (2016) (0)
- International Drug Control into the 21st Century [Book Review] (2009) (0)
- Chasing the Scream: The First and Last Days of the War on Drugs.Johann Hari London, United Kingdom: Bloomsbury Circus, 2015 ISBN 978-1-4088-5784-7 389 pp. Paperback. Price: $29.99 (2016) (0)
- Drug policies as laws and regulations, and policing (2021) (0)
- Bulletin No. 26: Models for the decriminalisation of the personal use and possession of drugs. (2018) (0)
- Analysing drug policy formation (2021) (0)
- "It's professional but it's personal": Participation, personal connection, and sustained disagreement in drug policy reform. (2022) (0)
- An overlooked effect: domestic violence and alcohol policies in the night-time economy. (2023) (0)
- Prescription drug monitoring programs in Australia: A call for a comprehensive evaluation. (2023) (0)
- Science, practice, experience APSAD 2005 (2006) (0)
- Australian drug trafficking laws: guilty until proven innocent? (2015) (0)
- Democratising drug policy (2021) (0)
- Thinking beyond the individual, a response to commentaries. (2021) (0)
- A comparison of structural features and vulnerability between government and nongovernment alcohol and other drug (AOD) treatment providers. (2021) (0)
- Established Tables and Emergent Huddles: Exploring the Processes of Participation Associated With the Policy Changes to Opioid Pharmacotherapy Treatment in Australia in the Context of COVID-19 (2022) (0)
- Individual-Level Simulation Model For Cost Benefit Analysis In Healthcare (2016) (0)
- The privileged role of researchers in 'evidence-based' policy: policy processes and implications for other voices in the drug policy landscape (2014) (0)
- How to decriminalize drugs: the design features of a non-criminal response to the personal possession of drugs (2021) (0)
- Drug policies to improve health and reduce harm (2021) (0)
- Impact of Addictive Substances and Behaviours on Individual and Societal Well-Being edited by PeterAnderson, JürgenRehm & RobinRoom (Eds) Oxford, UK: Oxford University Press, 2015 ISBN 978-0-19-871400-2, 272 pp. Paperback. Price: £29.99: Critiques (2016) (0)
- Influencing drug policy (2021) (0)
- Sociometric network analysis in illicit drugs research: A scoping review (2023) (0)
- 39. I2S Needs Theory as Well as a Toolkit (2015) (0)
- The impact of tableside ordering technologies on alcohol sales to the intoxicated. (2023) (0)
- Analysing the discursive effects of drug policy (2021) (0)
- Piloting a classification framework for the types of evidence used in alcohol policymaking. (2023) (0)
- The Cost Effectiveness of Buprenorphine in a Primary Care Setting: A Randomised Controlled Trial (2003) (0)
- Second Annual Conference of the International Society for the Study of Drug Policy : April 3-4 2008 , Lisbon , Portugal (2008) (0)
- Assessing the risks and rewards of crime:: Decision making and deterrence in drug trafficking offenders (2011) (0)
- New Pharmacotherapies: Improving Treatment Choices for Heroin Users in Victoria (2001) (0)
- Letters to the Editor Comments on Ritter Et Al .'s Report of a Comparative Trial of Laam and Methadone Maintenance (0)
- Drug policies and research evidence (2021) (0)
- Citizens’ juries and their role in improved alcohol policy: damp squib, or useful tool? (2022) (0)
- Randomised controlled trials (2005) (0)
- LAAM vs. methadone: a response to Caplehorn (2004) (0)
- Book Reviews (2009) (0)
- Intangible outcomes from a policy change: using contingent valuation to quantify potential stigma from a cannabis offence (2013) (0)
- HARMS TO RESIDENT ADULTS AND ADULT FAMILY MEMBERS OF A PERSON DEPENDENT ON METHAMPHETAMINE: COUNTING THE COSTS (2018) (0)
- Keeping I 2 S Grounded in Research Practice (2015) (0)
- Prioritizing measures to assess performance of drug treatment services: a Delphi process with funders, treatment providers and service‐users (2022) (0)
- Pharmacotherapies and pregnancy (2009) (0)
- Responding to mental health issues without alcohol and drug treatment (2007) (0)
- MONOGRAPH 09 HEROIN MARKETS IN AUSTRALIA : CURRENT UNDERSTANDINGS AND FUTURE POSSIBILITIES (2006) (0)
- Findings regarding reduced prevalence with hepatitis C treatment are still valid: A reply to Vickerman et al. (2011) (0)
This paper list is powered by the following services:
Other Resources About Alison Ritter
What Schools Are Affiliated With Alison Ritter?
Alison Ritter is affiliated with the following schools:
